1.
Samura BB. Interactions between galectin-3 and cardiovascular risk in patients with chronic lymphocytic leukemia in remission: results of 3-year prospective study. Current issues in pharmacy and medicine: science and practice [Internet]. 2018Oct.24 [cited 2024Jul.24];(3). Available from: http://pharmed.zsmu.edu.ua/article/view/145251